Literature DB >> 18370385

Solid-state NMR spectroscopy of human immunodeficiency virus fusion peptides associated with host-cell-like membranes: 2D correlation spectra and distance measurements support a fully extended conformation and models for specific antiparallel strand registries.

Wei Qiang1, Michele L Bodner, David P Weliky.   

Abstract

The human immunodeficiency virus (n class="Disease">HIV) is "enveloped" by a membrane, and infection of a host cell begins with fusion between viral and target cell membranes. Fusion is catalyzed by the HIV gp41 protein which contains a functionally critical approximately 20-residue apolar "fusion peptide" (HFP) that associates with target cell membranes. In this study, chemically synthesized HFPs were associated with host-cell-like membranes and had "scatter-uniform" labeling (SUL), that is, only one residue of each amino acid type was U-(13)C, (15)N labeled. For the first sixteen HFP residues, an unambiguous (13)C chemical shift assignment was derived from 2D (13)C/(13)C correlation spectra with short mixing times, and the shifts were consistent with continuous beta-strand conformation. (13)C-(13)C contacts between residues on adjacent strands were derived from correlation spectra with long mixing times and suggested close proximity of the following residues: Ala-6/Gly-10, Ala-6/Phe-11, and Ile-4/Gly-13. Specific antiparallel beta-strand registries were further tested using a set of HFPs that were (13)CO-labeled at Ala-14 and (15)N-labeled at either Val-2, Gly-3, Ile-4, or Gly-5. The solid-state NMR data were fit with 50-60% population of antiparallel HFP with either Ala-14/Gly-3 or Ala-14/Ile-4 registries and 40-50% population of structures not specified by the NMR experiments. The first two registries correlated with intermolecular hydrogen bonding of 15-16 apolar N-terminal residues and this hydrogen-bonding pattern would be consistent with a predominant location of these residues in the hydrophobic membrane interior. To our knowledge, these results provide the first residue-specific structural models for membrane-associated HFP in its beta-strand conformation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18370385      PMCID: PMC4487652          DOI: 10.1021/ja077302m

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  80 in total

1.  Solid state NMR measurements of conformation and conformational distributions in the membrane-bound HIV-1 fusion peptide.

Authors:  J Yang; P D Parkanzky; B A Khunte; C G Canlas; R Yang; C M Gabrys; D P Weliky
Journal:  J Mol Graph Model       Date:  2001       Impact factor: 2.518

2.  A trimeric HIV-1 fusion peptide construct which does not self-associate in aqueous solution and which has 15-fold higher membrane fusion rate.

Authors:  Rong Yang; Mary Prorok; Francis J Castellino; David P Weliky
Journal:  J Am Chem Soc       Date:  2004-11-17       Impact factor: 15.419

3.  Structural model of the membrane-bound C terminus of lipid-modified human N-ras protein.

Authors:  Guido Reuther; Kui-Thong Tan; Julia Köhler; Christine Nowak; André Pampel; Klaus Arnold; Jürgen Kuhlmann; Herbert Waldmann; Daniel Huster
Journal:  Angew Chem Int Ed Engl       Date:  2006-08-11       Impact factor: 15.336

4.  High-resolution conformation of gramicidin A in a lipid bilayer by solid-state NMR.

Authors:  R R Ketchem; W Hu; T A Cross
Journal:  Science       Date:  1993-09-10       Impact factor: 47.728

5.  15N NMR study of the ionization properties of the influenza virus fusion peptide in zwitterionic phospholipid dispersions.

Authors:  Z Zhou; J C Macosko; D W Hughes; B G Sayer; J Hawes; R M Epand
Journal:  Biophys J       Date:  2000-05       Impact factor: 4.033

6.  Protein backbone angle restraints from searching a database for chemical shift and sequence homology.

Authors:  G Cornilescu; F Delaglio; A Bax
Journal:  J Biomol NMR       Date:  1999-03       Impact factor: 2.835

7.  Structure of tightly membrane-bound mastoparan-X, a G-protein-activating peptide, determined by solid-state NMR.

Authors:  Yasuto Todokoro; Ikuko Yumen; Kei Fukushima; Shin-Won Kang; Jang-Su Park; Toshiyuki Kohno; Kaori Wakamatsu; Hideo Akutsu; Toshimichi Fujiwara
Journal:  Biophys J       Date:  2006-05-19       Impact factor: 4.033

8.  Lipid composition and fluidity of the human immunodeficiency virus envelope and host cell plasma membranes.

Authors:  R C Aloia; H Tian; F C Jensen
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

9.  Chemical shift referencing in MAS solid state NMR.

Authors:  Corey R Morcombe; Kurt W Zilm
Journal:  J Magn Reson       Date:  2003-06       Impact factor: 2.229

10.  Interaction of the HIV-1 fusion peptide with phospholipid vesicles: different structural requirements for fusion and leakage.

Authors:  J L Nieva; S Nir; A Muga; F M Goñi; J Wilschut
Journal:  Biochemistry       Date:  1994-03-22       Impact factor: 3.162

View more
  36 in total

1.  Irregular structure of the HIV fusion peptide in membranes demonstrated by solid-state NMR and MD simulations.

Authors:  Dorit Grasnick; Ulrich Sternberg; Erik Strandberg; Parvesh Wadhwani; Anne S Ulrich
Journal:  Eur Biophys J       Date:  2011-01-28       Impact factor: 1.733

Review 2.  Biochemistry and biophysics of HIV-1 gp41 - membrane interactions and implications for HIV-1 envelope protein mediated viral-cell fusion and fusion inhibitor design.

Authors:  Lifeng Cai; Miriam Gochin; Keliang Liu
Journal:  Curr Top Med Chem       Date:  2011-12       Impact factor: 3.295

3.  Major antiparallel and minor parallel β sheet populations detected in the membrane-associated human immunodeficiency virus fusion peptide.

Authors:  Scott D Schmick; David P Weliky
Journal:  Biochemistry       Date:  2010-11-24       Impact factor: 3.162

4.  A strong correlation between fusogenicity and membrane insertion depth of the HIV fusion peptide.

Authors:  Wei Qiang; Yan Sun; David P Weliky
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-24       Impact factor: 11.205

5.  HIV gp41 six-helix bundle constructs induce rapid vesicle fusion at pH 3.5 and little fusion at pH 7.0: understanding pH dependence of protein aggregation, membrane binding, and electrostatics, and implications for HIV-host cell fusion.

Authors:  Kelly Sackett; Allan TerBush; David P Weliky
Journal:  Eur Biophys J       Date:  2011-01-11       Impact factor: 1.733

6.  Solid-state nuclear magnetic resonance measurements of HIV fusion peptide 13CO to lipid 31P proximities support similar partially inserted membrane locations of the α helical and β sheet peptide structures.

Authors:  Charles M Gabrys; Wei Qiang; Yan Sun; Li Xie; Scott D Schmick; David P Weliky
Journal:  J Phys Chem A       Date:  2013-02-28       Impact factor: 2.781

7.  Solid-state nuclear magnetic resonance (NMR) spectroscopy of human immunodeficiency virus gp41 protein that includes the fusion peptide: NMR detection of recombinant Fgp41 in inclusion bodies in whole bacterial cells and structural characterization of purified and membrane-associated Fgp41.

Authors:  Erica P Vogel; Jaime Curtis-Fisk; Kaitlin M Young; David P Weliky
Journal:  Biochemistry       Date:  2011-10-31       Impact factor: 3.162

Review 8.  Magic angle spinning NMR of viruses.

Authors:  Caitlin M Quinn; Manman Lu; Christopher L Suiter; Guangjin Hou; Huilan Zhang; Tatyana Polenova
Journal:  Prog Nucl Magn Reson Spectrosc       Date:  2015-02-16       Impact factor: 9.795

9.  Residue-specific membrane location of peptides and proteins using specifically and extensively deuterated lipids and ¹³C-²H rotational-echo double-resonance solid-state NMR.

Authors:  Li Xie; Ujjayini Ghosh; Scott D Schmick; David P Weliky
Journal:  J Biomol NMR       Date:  2012-12-08       Impact factor: 2.835

10.  Comparative analysis of membrane-associated fusion peptide secondary structure and lipid mixing function of HIV gp41 constructs that model the early pre-hairpin intermediate and final hairpin conformations.

Authors:  Kelly Sackett; Matthew J Nethercott; Raquel F Epand; Richard M Epand; Douglas R Kindra; Yechiel Shai; David P Weliky
Journal:  J Mol Biol       Date:  2010-01-18       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.